According to Cardiovascular Systems's latest financial reports and stock price the company's current Operating Margin is -15.72%. At the end of 2022 the company had an Operating Margin of -14.81%.
Year | Operating Margin | Change |
---|---|---|
2022 | -14.81% | 235.48% |
2021 | -4.42% | -58.28% |
2020 | -10.58% | -1721.12% |
2019 | 0.65% | -60.21% |
2018 | 1.64% | -378.76% |
2017 | -0.59% | -98.13% |
2016 | -31.44% | 74.03% |
2015 | -18.07% | -27.95% |
2014 | -25.08% | 14.81% |
2013 | -21.84% | 24.54% |
2012 | -17.54% | 56.83% |
2011 | -11.18% | -68.34% |
2010 | -35.32% | -41.74% |
2009 | -60.63% | |
2007 | 3.82% | -101.77% |
2006 | -215.75% | -97.21% |
2005 | -7,725.17% | 249.35% |
2004 | -2,211.27% | -2311.27% |
2003 | 100.00% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | 22.88% | -245.55% | ๐บ๐ธ USA |
Medtronic MDT | 17.17% | -209.22% | ๐ฎ๐ช Ireland |
Boston Scientific BSX | 11.27% | -171.69% | ๐บ๐ธ USA |
Merit Medical MMSI | 7.17% | -145.61% | ๐บ๐ธ USA |
LeMaitre Vascular LMAT | 16.26% | -203.44% | ๐บ๐ธ USA |
AngioDynamics ANGO | -11.74% | -25.32% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.